{"id":10154,"date":"2026-06-11T01:59:01","date_gmt":"2026-06-10T22:59:01","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10154"},"modified":"2026-06-11T01:59:01","modified_gmt":"2026-06-10T22:59:01","slug":"european-heart-journal-2026","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/european-heart-journal-2026\/","title":{"rendered":"European Heart Journal 2026"},"content":{"rendered":"<p><span>European Heart Journal 2026<\/span><\/p>\n<p><span>Optimal Potassium Range in Heart Failure: 4.2\u20135.0 mmol\/L<\/span><\/p>\n<p><span>* Individual patient-level meta-analysis of 12 randomized HF trials including more than 46,000 patients with HFrEF and HFpEF.<\/span><br \/>\n<span>* Across both HF phenotypes, a serum potassium level of 4.2\u20135.0 mmol\/L was associated with the lowest risk of death and first HF hospitalization.<\/span><br \/>\n<span>* In HFrEF, hypokalemia (&lt;3.5 mmol\/L) was associated with a 49% higher risk of all-cause mortally<\/span><\/p>\n<p><span>* Mild hyperkalemia (5.0\u20135.5 mmol\/L) was not associated with excess risk<\/span><\/p>\n<p><span>Source: European Heart Journal \u2014 University of Glasgow. Published online, Oxford Academic, May 28, 2026.<\/span><br \/>\n<a href=\"https:\/\/doi.org\/10.1093\/eurheartj\/ehag341\" target=\"_blank\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/doi.org\/10.1093\/eurheartj\/ehag341&amp;source=gmail&amp;ust=1781218711500000&amp;usg=AOvVaw2jpNUqIT-nYbMz9cyuicyt\" rel=\"noopener\">https:\/\/doi.org\/10.1093\/<wbr \/>eurheartj\/ehag341<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>European Heart Journal 2026 Optimal Potassium Range in Heart Failure: 4.2\u20135.0 mmol\/L * Individual patient-level meta-analysis of 12 randomized HF trials including more than 46,000 patients with HFrEF and HFpEF. * Across both HF phenotypes, a serum potassium level of 4.2\u20135.0 mmol\/L was associated with the lowest risk of death and first HF hospitalization. * [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10154","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10154"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10154\/revisions"}],"predecessor-version":[{"id":10155,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10154\/revisions\/10155"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}